SOS1 could promote the phosphorylation of extracellular signal-regulating kinases 1/2 (ERK1/2) and activate the ERK/nuclear factor-κB (NF-κB) signaling pathway, which aggravates oxidative stress after stroke. The gene discussed is MAPK3; the disease is stroke disorder.